StockVS

NYSE · Healthcare Plans · USD

The Cigna Group (CI) Stock Analysis

The Cigna Group (CI) is a Healthcare Plans stock listed on NYSE and quoted in US Dollar.

CI

$282.52

−$3.74 (−1.31%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CI with… →

CI Key Statistics

As of Sep 4, 2026
Trading
Open
$283.06
Previous Close
$286.26
Day's Range
281.63–284.67
52-Week Range
239.51–315.47
Volume
1.20M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.32
Valuation
Market Cap
$74.65B
P/E Ratio
11.68
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
8.44
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.78
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.26
EPS (ttm)Profit attributable to each share over the last twelve months.
24.19
Financials (FY)
Revenue (FY)
$273.85B+11.26%
Net Income (FY)
$5.96B+73.47%
Profit marginThe share of revenue left as profit after all costs and taxes.
2.27%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
264.24M
1-Year Return
−5.49%
Dividend and dates
Dividend
$6.24+2.18%
Ex-Dividend Date
September 8, 2026
Earnings Date
November 5, 2026
Avg Volume
1.67M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

CI Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+3.81%
2025+1.72%
2024−6.27%
2023−7.97%
2022+46.68%
2021+12.29%
2020+1.83%
2019+7.70%
2018−6.46%
2017+52.29%
2016 (partial year)+3.89%

As of September 4, 2026.

CI Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$273.85B$5.96B2.2%
2024$246.15B$3.43B1.4%
2023$194.10B$5.16B2.7%
2022$179.36B$6.70B3.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$273.85B$24.51B$8.15B$5.96B2.2%
2024$246.15B$24.99B$8.44B$3.43B1.4%
2023$194.10B$24.01B$7.37B$5.16B2.7%
2022$179.36B$22.35B$7.30B$6.70B3.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

CI Dividend History

$6.04+7.9% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$3.122
2025$6.044+7.9%
2024$5.604+13.8%
2023$4.924+9.8%
YearDividends per sharePaymentsChange
2026 (partial year)$3.122
2025$6.044+7.9%
2024$5.604+13.8%
2023$4.924+9.8%
2022$4.484+12.0%
2021$4.004+9900.0%
2020$0.041+0.0%
2019$0.041+0.0%
2018$0.041+0.0%
2017$0.041

Most recent payment: $1.56 per share, ex-dividend June 4, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

CI Valuation vs Healthcare Plans Median

Median of 11 stocks
MetricCIHealthcare Plans medianvs median
P/E11.6825.6654% below
P/S ratio0.260.4440% below
Profit margin2.27%1.18%1.1 pts above

Medians across 11 Healthcare Plans stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The Cigna Group (CI) is capitalised at $74.65B on the latest close. It is classified in the Healthcare Plans industry, within the Healthcare sector. The company reports 65,669 employees.

CI last closed at $282.52 on September 4, 2026. That is −$3.74 (−1.31%) against the previous close. The 52-week range on file runs from $239.51 to $315.47. The latest close sits 17.96% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $273.85B. Against the prior fiscal year total of $246.15B, that is a change of +11.26%. Net income for the same year was $5.96B. That is +73.47% against the prior fiscal year. Profit margin runs at 2.27%. That is 1.1 percentage points above the Healthcare Plans median of 1.18%. Earnings per share on a trailing basis come to 24.19.

Across the 4 fiscal years on file, revenue moves from $179.36B in 2022 to $273.85B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 11.68 times earnings. That is 54.48% below the Healthcare Plans median of 25.66. On forward earnings the ratio is 8.44. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.78. The price-to-sales ratio is 0.26. On price-to-sales that is 39.84% below the Healthcare Plans median of 0.44. The medians here are taken across 11 Healthcare Plans companies that report the metric.

The trailing one-year price return is −5.49%. Measured over 10 years, that is +9.32% a year compounded. Beta against the wider market is reported at 0.32. Annualized volatility over the trailing 10 years is 30.7%.

Growth & Income

The trailing dividend yield is 2.18%. The indicated annual rate is $6.24 a share. The ex-dividend date on file is September 8, 2026. Dividends are recorded for 10 calendar years; 2026 shows 2 payments totalling $3.12 a share. The year before, 2025, totalled $6.04 a share.

Across the complete calendar years on file, 2017 returned +52.29% and 2023 returned −7.97%. Of the 9 complete calendar years on file, 6 finished higher. So far in 2026 the price is +3.81%.

Peer Comparison

The Cigna Group (CI) operates in the Healthcare Plans industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
The Cigna Group CI $74.65B 11.7
UnitedHealth Group Incorporated UNH $356.47B 25.5
CVS Health Corporation CVS $123.73B 25.7
Elevance Health, Inc. ELV $88.37B 18.4

The Healthcare Plans industry average P/E ratio is 25.7x. The Cigna Group trades at a P/E of 11.7.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Healthcare Plans Stocks

View all Healthcare Plans stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Visit website →